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Abstract
An Escherichia coli isolate co-producing VIM-4 metallo-b-lactamase and CTX-M-15 extended spectrum b-lactamase was recovered from
the urine of a patient with head trauma in Moscow, Russia. The blaVIM-4 and blaCTX-M-15 genes were carried, respectively, by transmissi-
ble plasmids of IncW and IncI1 groups. The nucleotide sequence of the VIM-4-encoding integron was nearly identical to that of In416,
which represent a large group of structurally related integrons previously found in Enterobacteriaceae all around the Mediterranean basin.
This is the first report of a metallo-b-lactamase-producing E. coli in Russia.
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Abstract
Increasing diversity of available medical applications (apps) has led to their widespread use in healthcare delivery. However, app involve-
ment in diagnosis and patient management has raised concerns, specifically regarding accuracy and reliability of content. Here, we report
on the contemporary range of microbiology-themed apps and prevalence of medical professional involvement in app development. Of
94 microbiology-themed apps identified, only 34% had stated medical professional involvement. The lack of such involvement in app
design is concerning and undermines consumers’ ability to be informed regarding quality of content. We propose that increased regula-
tory measures are introduced to safeguard patient welfare.
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